Clinical Trial Update: The Pristine Post-Market Study [NA]

View source ↗

Summary

The study was terminated; results have been posted for a post-market safety/efficacy evaluation related to dialysis-related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hemodialysis Complication
• Hemodialysis-related Infection

Drugs mentioned

• Bard Catheter (unspecified model) / Bard

Snippet

Sponsor: C. R. Bard | Conditions: Kidney Failure, Chronic, Hemodialysis Complication | NA | Status: TERMINATED | Results posted: 2024-04-11